Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests...

Area of Science:

• Gynecology
• Oncology
• Pathology

Background:

• The 2019 ASCCP Risk Based Management Consensus Guidelines represent an advancement in cervical cancer prevention.
• These guidelines integrate a deeper understanding of HPV biology and cervical carcinogenesis.
• Pathology organizations played a key role in their development.

Purpose of the Study:

• To summarize guideline changes relevant to laboratory professionals.
• To discuss prior recommendations and potential modifications for laboratory practices.

Main Methods:

• Utilizing HPV-based testing for risk estimation.
• Incorporating current and prior results for personalized risk assessment.
• Streamlining the integration of newly validated testing methods.

Main Results:

• Guidelines support "equal management for equal risk" and "balancing harms and benefits".
• Updated recommendations accommodate decreasing CIN3+ risks due to HPV vaccination.
• Focus on adapting laboratory practices to new guidelines.

Conclusions:

• The 2019 ASCCP guidelines offer a risk-based approach to cervical cancer prevention.
• These guidelines are adaptable to evolving screening technologies and population changes.
• Implementation requires consideration of laboratory practice modifications.